NCT00558012View on ClinicalTrials.gov

Zoledronic Acid for Osteoporosis in the Elderly

NACompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
OsteoporosisBone LossFragility Fractures
Interventions
DRUG

Intravenous zoledronic acid

Intravenous zoledronic acid 5.0 mg once

DIETARY_SUPPLEMENT

Vitamin D 800 IU/daily

Daily divided dose

DIETARY_SUPPLEMENT

Calcium 1200 mg/daily

supplement plus diet

Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Aging (NIA)

NIH

lead

University of Pittsburgh

OTHER

NCT00558012 - Zoledronic Acid for Osteoporosis in the Elderly | Biotech Hunter | Biotech Hunter